M. Anne Szostak's most recent trade in Idexx Laboratories, Inc. was a trade of 2,187 Non-Qualified Stock Option (right-to-buy) done . Disclosure was reported to the exchange on Aug. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 2,187 | 0 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 647.33 per share. | 22 Aug 2025 | 2,187 | 262 (0%) | 0% | 647.3 | 1,415,700 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 206.62 per share. | 22 Aug 2025 | 2,187 | 2,449 (0%) | 0% | 206.6 | 451,878 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 259 | 1,542 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Aug 2025 | 259 | 259 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 512.34 per share. | 21 May 2025 | 1,260 | 1,801 (0%) | 0% | 512.3 | 645,545 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.28 per share. | 21 May 2025 | 1,046 | 1,308 (0%) | 0% | 160.3 | 167,653 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 513.74 per share. | 21 May 2025 | 1,046 | 262 (0%) | 0% | 513.7 | 537,372 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 1,046 | 0 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 600 | 600 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2025 | 262 | 262 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2025 | 262 | 0 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 257 | 257 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 465.94 per share. | 07 Feb 2025 | 3,000 | 3,061 (0%) | 0% | 465.9 | 1,397,835 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Sep 2024 | 500 | 500 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 469.37 per share. | 05 Sep 2024 | 500 | 0 (0%) | 0% | 469.4 | 234,686 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Sep 2024 | 500 | 6,061 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 609 | 609 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2024 | 262 | 262 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2024 | 257 | 6,561 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2024 | 257 | 0 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 257 | 257 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2024 | 257 | 0 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 645 | 645 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 257 | 257 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 344 | 0 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2023 | 344 | 1,604 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 475.27 per share. | 05 May 2023 | 800 | 5,200 (0%) | 0% | 475.3 | 380,216 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 473.59 per share. | 05 May 2023 | 700 | 6,000 (0%) | 0% | 473.6 | 331,513 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 476.12 per share. | 05 May 2023 | 500 | 4,700 (0%) | 0% | 476.1 | 238,060 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 5,816 | 6,700 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 5,816 | 741 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 371 | 370 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Feb 2023 | 370 | 0 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 2,000 | 1,046 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.28 per share. | 02 Dec 2022 | 2,000 | 2,000 (0%) | 0% | 160.3 | 320,560 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 428.55 per share. | 02 Dec 2022 | 740 | 1,260 (0%) | 0% | 428.6 | 317,127 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 945 | 945 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 344 | 568 | - | - | Restricted Stock Unit | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 224 | 224 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2022 | 224 | 344 | - | - | Restricted Stock Unit | |
| Tupperware Brands Corporation | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 9.93 per share. | 06 May 2022 | 15,106 | 88,858 (0%) | 0% | 9.9 | 150,003 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 660 | 660 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Feb 2022 | 660 | 6,557 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 693.91 per share. | 06 Aug 2021 | 595 | 7,222 (0%) | 0% | 693.9 | 412,875 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 684.96 per share. | 06 Aug 2021 | 439 | 8,978 (0%) | 0% | 685.0 | 300,696 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 682.77 per share. | 06 Aug 2021 | 368 | 9,537 (0%) | 0% | 682.8 | 251,260 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 681.49 per share. | 06 Aug 2021 | 312 | 9,905 (0%) | 0% | 681.5 | 212,625 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 691.75 per share. | 06 Aug 2021 | 300 | 7,817 (0%) | 0% | 691.7 | 207,524 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 690.65 per share. | 06 Aug 2021 | 300 | 8,117 (0%) | 0% | 690.7 | 207,195 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 689.60 per share. | 06 Aug 2021 | 300 | 8,417 (0%) | 0% | 689.6 | 206,881 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 685.98 per share. | 06 Aug 2021 | 261 | 8,717 (0%) | 0% | 686.0 | 179,042 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 683.71 per share. | 06 Aug 2021 | 120 | 9,417 (0%) | 0% | 683.7 | 82,045 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 694.60 per share. | 06 Aug 2021 | 5 | 7,217 (0%) | 0% | 694.6 | 3,473 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 723 | 723 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 224 | 224 | - | - | Restricted Stock Unit | |
| Tupperware Brands Corporation | M. Anne Szostak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 7,236 | 73,752 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2021 | 11,876 | 11,876 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2021 | 11,876 | 0 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2021 | 10,217 | 0 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2021 | 10,217 | 10,217 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2021 | 10,217 | 0 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Feb 2021 | 10,217 | 10,217 (0%) | 0% | 0 | Common Stock | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.69 per share. | 04 Feb 2021 | 5,974 | 5,974 (0%) | 0% | 64.7 | 386,458 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 5,974 | 0 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.00 per share. | 04 Feb 2021 | 5,902 | 11,876 (0%) | 0% | 85 | 501,670 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2021 | 5,902 | 0 | - | - | Non-Qualified Stock Option (right-to-buy) | |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 489.23 per share. | 04 Feb 2021 | 4,286 | 4,799 (0%) | 0% | 489.2 | 2,096,836 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 490.70 per share. | 04 Feb 2021 | 3,399 | 1,400 (0%) | 0% | 490.7 | 1,667,879 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 488.24 per share. | 04 Feb 2021 | 2,791 | 9,085 (0%) | 0% | 488.2 | 1,362,666 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 491.56 per share. | 04 Feb 2021 | 1,100 | 300 (0%) | 0% | 491.6 | 540,716 | Common Stock |
| IDEXX Laboratories | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 492.39 per share. | 04 Feb 2021 | 300 | 0 (0%) | 0% | 492.4 | 147,718 | Common Stock |
| Tupperware Brands Corporation | M. Anne Szostak | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Nov 2020 | 3,040 | 68,368 (0%) | 0% | 0 | Common Stock | |
| Tupperware Brands Corporation | M. Anne Szostak | Director | Sale of securities on an exchange or to another person at price $ 28.43 per share. | 10 Nov 2020 | 1,000 | 71,408 (0%) | 0% | 28.4 | 28,430 | Common Stock |